Age-related macular degeneration and Occlusion - renal artery

Summary:

Occlusion - renal artery is reported only by a few people with Age-related macular degeneration.

The study analyzes which people have Occlusion - renal artery with Age-related macular degeneration. It is created by eHealthMe based on 1 person who has Occlusion - renal artery and Age-related macular degeneration from the Food and Drug Administration (FDA), and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Feb, 07, 2023

1 person who has Age-Related Macular Degeneration and Occlusion - Renal Artery is studied.

What is Age-related macular degeneration?

Age-related macular degeneration is found to be associated with 535 drugs and 274 conditions by eHealthMe.

What is Occlusion - renal artery?

Occlusion - renal artery (a blockage of the major arteries that supply blood to the kidneys) is found to be associated with 1,225 drugs and 705 conditions by eHealthMe.

Number of Occlusion - renal artery in Age-related macular degeneration reports submitted per year:

Would you have Occlusion - renal artery when you have Age-related macular degeneration?

Gender of people who have Age-Related Macular Degeneration and experienced Occlusion - Renal Artery *:

female: 100 %
male: 0.0 %

Age of people who have Age-Related Macular Degeneration and experienced Occlusion - Renal Artery *:

Common symptoms for these people *:

High Blood Pressure: 1 person, 100.00%
Cardiac Failure: 1 person, 100.00%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Occlusion - renal artery?

Check whether Occlusion - renal artery is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Treatments, associated drugs and conditions:

Age-related macular degeneration (10,505 reports)
Occlusion - renal artery (2,552 reports)

COVID vaccines that are related to Occlusion - renal artery:

Common drugs associated with Occlusion - renal artery:

All the drugs that are associated with Occlusion - renal artery:

Occlusion - renal artery (1,225 drugs)

Common conditions associated with Occlusion - renal artery:

All the conditions that are associated with Occlusion - renal artery:

Occlusion - renal artery (705 conditions)

How the study uses the data?

The study is based on Occlusion - renal artery and Age-related macular degeneration, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.